In a remarkable leap forward for oncology, scientists at Rice University have developed “molecular jackhammers” that use infrared light to physically destroy cancer cells. These specialized molecules, derived from imaging dyes, attach to cancerous tissues and begin vibrating violently when hit with near-infrared light. This vibration ruptures cancer cell membranes—without generating heat, chemicals, or radiation. The result? Up to 99% of melanoma cells destroyed in lab tests, with similar success seen in animal models.

Unlike chemotherapy or radiation, this treatment is non-toxic and highly targeted, sparing healthy cells from harm. Because near-infrared light penetrates deep into the body, the technique holds promise for non-invasive treatment of internal tumors. Even better, the molecules remain inert until activated by light, minimizing side effects and maximizing control. With its foundation already built on FDA-approved imaging dyes, this could enter clinical trials in just a few years—signaling a bold new chapter in cancer therapy.

#CancerTreatment #InfraredTherapy #Nanomedicine #MedicalInnovation #MolecularEngineering
In a remarkable leap forward for oncology, scientists at Rice University have developed “molecular jackhammers” that use infrared light to physically destroy cancer cells. These specialized molecules, derived from imaging dyes, attach to cancerous tissues and begin vibrating violently when hit with near-infrared light. This vibration ruptures cancer cell membranes—without generating heat, chemicals, or radiation. The result? Up to 99% of melanoma cells destroyed in lab tests, with similar success seen in animal models. Unlike chemotherapy or radiation, this treatment is non-toxic and highly targeted, sparing healthy cells from harm. Because near-infrared light penetrates deep into the body, the technique holds promise for non-invasive treatment of internal tumors. Even better, the molecules remain inert until activated by light, minimizing side effects and maximizing control. With its foundation already built on FDA-approved imaging dyes, this could enter clinical trials in just a few years—signaling a bold new chapter in cancer therapy. #CancerTreatment #InfraredTherapy #Nanomedicine #MedicalInnovation #MolecularEngineering
0 Commentarios 0 Acciones 23K Views